Why are most genomic studies conducted in high-income countries?

High-income countries have greater access to funding, advanced infrastructure, and research capacity, leading to their dominance in genomic studies.

What is the WHO's stance on genomic research in low-income countries?

The WHO calls for increased investment and coordinated global action to ensure genomic research contributes to health equity and includes underrepresented regions.

Why are infectious diseases neglected in genomic studies?

Despite being global health priorities, infectious diseases account for only 3% of genomic studies, indicating a lack of focus compared to cancer and rare diseases.

Home / Science / Genomic Research Skewed: High-Income Nations Dominate Studies

Genomic Research Skewed: High-Income Nations Dominate Studies

23 Dec

•

Summary

Over 80% of global genomic disease studies are in high-income countries.
Fewer than 5% of studies are from low and middle-income countries.
Infectious diseases represent only 3% of genomic research.

Genomic Research Skewed: High-Income Nations Dominate Studies

A comprehensive global analysis by the World Health Organization highlights a significant disparity in genomic research, with high-income countries dominating over 80% of studies on diseases. Conversely, low and middle-income countries (LMICs) account for less than five percent, despite being included as study sites in multicountry initiatives. China, the United States, and Italy lead in registered genomic clinical studies.

While cancer, rare diseases, and metabolic disorders comprise over 75% of genomic research, infectious diseases like tuberculosis, HIV, and malaria are significantly underrepresented, making up just three percent of studies. This trend signifies a missed opportunity to apply genomic insights to critical global health priorities, particularly in low-resource settings.